semaglutide and colon cancer GLP-1 drugs cancer: the headline is exciting. The full picture is more nuanced. New research from @ascocancer 2026 shows patients on GLP-1 medications like were up to 50% less likely GLP-1 Weight-Loss Drugs May Boost

"That being said, everyone I've spoken to is very hopeful that this can be beneficial for cancer patients." Colon cancer is quickly becoming one of the deadliest cancers in young people

Manufactured by Novo Nordisk, semaglutide is a GLP-1 receptor agonist (glucagon-like peptide-1) that is used to improve blood sugar control (Ozempic and Rybelsus) in individuals with type 2 diabetes mellitus and to support chronic weight management (Wegovy) in individuals who are obese or overweight

The UAEs harsh sun and humidity can worsen skin concerns like pigmentation and uneven tone

This is why peptides for weight loss and muscle gain often include growth hormone secretagogues as foundational compounds

Liu X, Yu Z, Huang X, Gao Y, Wang X, Gu J, et al